SCHEMBL5110048

SCHEMBL5110048

Cc1cc(COc2c(Br)cc(CC(F)C(=O)O)cc2Br)cc(NC(=O)C(C)C)c1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
THRA P10827 8/20 0.40
THRB P10828 8/20 0.40
KMT2A Q03164 4/20 0.39
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
SENP5 Q96HI0 1/20 0.37
SENP2 Q9HC62 1/20 0.37
SENP1 Q9P0U3 1/20 0.37
DHODH Q02127 2/20 0.36
MEN1 O00255 1/20 0.35
FFAR1 O14842 1/20 0.35
PTGER1 P34995 2/20 0.35
HTT P42858 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5722495 0.95 THRA (0.37) THRATHRBKMT2AALDH1A1MAPT
SCHEMBL5104161 0.90 KMT2A (0.39) THRATHRBKMT2AALDH1A1MAPT
SCHEMBL5118803 0.90 THRA (0.39) THRATHRBKMT2AALDH1A1MAPT
SCHEMBL5116750 0.89 THRB (0.42) THRATHRBKMT2ADHODHMEN1
SCHEMBL5111457 0.88 THRB (0.40) THRATHRBKMT2AALDH1A1SENP5
SCHEMBL4934394 0.87 THRB (0.42) THRATHRBKMT2ADHODHMEN1
SCHEMBL4926936 0.87 THRB (0.43) THRATHRBFFAR1
SCHEMBL5107973 0.87 THRA (0.43) THRATHRBKMT2AALDH1A1MAPT
SCHEMBL5722499 0.86 THRA (0.35) THRATHRBKMT2AALDH1A1MAPT
SCHEMBL5722513 0.86 THRA (0.35) THRATHRBFFAR1PTGER1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA THRA 3/4885THRB 4/4885KMT2A 2895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.